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see it in elderly patients? The 30-year foll0w-up 
study of Buckwalter et al. would suggest not, but 
even longer observation is needed to be certain. 
Follicular carcinoma, which has a tendency to 
spread by blood vessel invasion and less often by 
regional lymphatics, had a 70% 5-year survival in 
the experience of Tollefsen and coworkers [2], pri- 
marily in adults. The same form of thyroid cancer in 
childhood is clearly less lethal and appears to be- 
have much like papillary disease. The same is true 
of mixed papillary-follicular disease as far as any- 
one can determine. 
Prior therapeutic irradiation to the thyroid region 
is almost certainly a factor that induces malignant 
changes in the gland of a susceptible host. The la- 
tent period is somewhere between 8 and 40 years. 
However, other factors must be involved since a 
history of prior irradiation is obtained in less than 
40% of patients in most series and in none of the 
patients in the series that our group reported [3]. 
Also, the study of Buckwalter et al. indicates that 
prior irradiation does not induce a more lethal form 
of cancer in children although multifocal disease 
that requires more aggressive therapy is more com- 
mon. Our recommendation for patients with a his- 
tory of prior irradiation is careful yearly physical 
examination, including an initial search for sub- 
sternal thyroid with a chest x-ray. Patients found to 
have single or multiple lesions are advised to have 
neck exploration. Those not found to have nodules 
on examination are subjected to periodic studies 
and 241Americuim scanning [2]. The latter tech- 
nique permits repeated evaluation without the in- 
troduction of radioactive materials into the body. 
Since it depends on external excitation of ejection 
of x-rays from intrathyroidal iodine, it is possible to 
compare normal thyroid to nodules. A nodular io- 
dine content ratio of less than 0.6 in comparison 
with normal surrounding thyroid usually indicates 
malignancy in our experience. We have generally 
not administered suppressive doses of thyroid hor- 
mone to patients with a history of prior irradiation 
who are being followed up, although others favor 
this practice. 
While information which may come to light in fu- 
ture years from the studies of Buckwalter et al. and 
others may change our current thinking, our present 
surgical recommendations are similar to theirs. 
Most agree that lobectomy and isthmusectomy are 
sufficient for unilobar disease, and that total or near 
total thyroidectomy is appropriate for those with 
multifocal, bilateral disease, for patients with bilat- 
eral nodal metastases, or for those with distant me- 
tastases. The risk of complications with total thy- 
roidectomy is high enough to restrict its use to situ- 
ations where the disease cannot be controlled 
otherwise. Our limited experience would indicate 
that total thyroidectomy does not protect against re- 
currence and, even if disease recurs following lo- 
bectomy, that patients can be successfully re- 
trieved. While Buckwalter et al. suggest near total 
thyroidectomy and modified neck dissection for pa- 
tients with unilateral disease and ipsilateral nodal 
involvement, we would reserve this approach, or 
perhaps use total thyroidectomy and modified neck 
dissection, under these circumstances for patients 
with follicular carcinoma, which seems to have a 
slightly higher recurrence rate than papillary carci- 
noma. Prophylactic neck dissection is not in order. 
All would agree that postoperative suppression with 
thyroid hormone is worthwhile and that radioiodine 
is a helpful adjunct for patients with distant metas- 
tases. However,  we must all acknowledge that only 
longitudinal studies such as the one reported here 
will give us the final answer. 
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As noted by the authors, primary carcinoma of the 
thyroid was considered rare in youth and particular- 
ly rare in children under 15 years of age before 1950. 
Although much has been written about the associa- 
tion of thyroid carcinomas and previous low-dose 
irradiation to the head and neck region, at least 1/z 
of all patients with thyroid carcinoma under 20 
years of age have not been exposed to therapeutic 
irradiation for benign conditions. Whether other un- 
identified initiating factors are responsible for the 
increased occurrence of this disease in the United 
States is unclear. Because children with dif- 
ferentiated thyroid cancers usually present with 
lymph node metastases, it is unlikely that many cas- 
es went unrecognized prior to 1950. 
The most surprising finding in this study is the 
high incidence of follicular carcinoma, particularly 
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in patients under 15 years of age. The 68% in- 
cidence reported by the authors is in sharp contrast 
to the 10% occurrence of follicular carcinomas 
noted by others in studying this age group of pa- 
tients [1-5]. In our reported series of 58 children 15 
years of age or younger, there were only 5 patients 
with follicular neoplasms [6]. By the current histo- 
logic criteria of the American Thyroid Association 3 
of these are now considered follicular variants of 
papillary carcinoma. In my opinion, classification of 
these neoplasms according to strict criteria is of 
more than semantic importance. Appropriate classi- 
fication has implications in selection of therapy, 
predictability of lymphatic pulmonary or bone me- 
tastases, prognosis, and ability to evaluate com- 
parable series. We agree with Frassila that papillary 
and follicular tumors can and should be specifically 
identified by strict histologic criteria [7]. We have 
found in both children and adults that there has 
been a significant decrease in the occurrence of fol- 
licular carcinomas during the past 2 decades. Dur- 
ing the same time period, papillary carcinoma has 
increased in occurrence. Papillary tumors now ac- 
count for more than 85% of the primary thyroid car- 
cinomas seen at the University of Michigan. To my 
knowledge there has been only one recent study 
showing an increasing incidence of follicular carci- 
nomas in patients under 40 years of age [8]. Wheth- 
er the same histological criteria advocated by Fras- 
sila and others were used in that report is not known. 
The most significant finding in the study of Buck- 
walter, Gurll, and Thomas is that nearly all patient s 
under 20 years of age with weU-differentiated thy- 
roid carcinomas eventually do well after definitive 
treatment. Life expectancy for this group of young 
patients is not significantly altered. Only 1 of 
their 68 patients followed up for as long as 30 years 
died from thyroid malignancy. Our results in treat- 
ing approximately 120 patients in this age group are 
very similar. In 1973 we reported our experience 
with 58 children who were 15 years of age or young- 
er. There were 51 children with papillary, 5 with fol- 
licular, and 2 with medullary carcinoma of the thy- 
roid. The average follow-up period for those pa- 
tients is now 23 years. In the 54 patients who had 
definitive treatment of well-differentiated thyroid 
carcinoma, there has been only 1 death. This result- 
ed from hepatocellular carcinoma developing in a 
patient 10 years after treatment of his papillary car- 
cinoma at age 11 years. Two 3-year-old patients 
died of pulmonary and tracheal involvement before 
any surgical treatment could be instituted. It is 
noteworthy that 63% of these children presented 
with cervical adenopathy due to metastatic papil- 
lary carcinoma. The incidence of proven lymphatic 
metastases was 88%. Local infiltration of tumor oc- 
curred in 31% and pulmonary metastases were pres- 
ent in 19%. Twenty-nine of the 54 children treated 
for differentiated thyroid carcinoma had received 
previous ionizing radiation to the head and neck. 
The average interval from exposure to diagnosis 
was 9.6 years. Definitive treatment in this group of 
children was total thyroidectomy in all but 3. In ad- 
dition 48 patients underwent lymph node excisions 
ranging from lymph node plucking to bilateral modi- 
fied and radical neck dissections. Radioactive io- 
dine was administered in therapeutic doses to 49 of 
the 54 patients with differentiated tumors, usually 6 
weeks after operation. 
The authors of the present paper suggest that the 
surgical approach should be dictated by "the bio- 
logical aggressiveness" of the disease. On the basis 
of our experience, but using their criteria, lobec- 
tomy would be rarely indicated in children. Lymph 
nodes metastases in this age group are almost al- 
ways present. The high incidence of bilateral meta- 
static cervical adenopathy (26%), pulmonary metas- 
tases (19%) and multifocal cancer would dictate that 
total or near total thyroidectomy would be recom- 
mended in nearly all patients under 15 years of age. 
In patients between 15 and 20 years of age we have 
also found a high incidence of metastatic disease at 
the time of diagnosis. We continue to treat proven 
follicular carcinoma by total thyroidectomy in order 
to be able to detect occult metastatic disease in 
bone or lung. We have not seen any patient under 
30 years of age with proven metastatic follicular 
carcinoma in lymph nodes. In all such designated 
cases, a careful review of the pathological material 
resulted in reclassification of the neoplasm as papil- 
lary carcinoma. We would agree with the authors 
that the goals of treatment are the removal of all 
thyroid carcinoma accessable to the surgeon, as 
much thyroid as possible without causing per- 
manent hypoparathyroidism, excision of all in- 
volved lymph nodes without deforming procedures, 
and therapeutic radioactive iodine for remote me- 
tastases. Despite the high incidence of cervical me- 
tastases in young patients, formal radical neck dis- 
section is rarely if ever required for differentiated 
thyroid carcinomas. Despite the presence of pulmo- 
nary metastases, effective treatment with 231I c a n  
be instituted after all normal thyroid tissue has been 
eradicated. In our experience these goals are best 
accomplished by early total thyroidectomy, pre- 
serving all parathyroid glands not involved with 
neoplasm, regional lymph node excision, and '3aI 
when indicated. Although this approach is also em- 
pirical, accomplishment of these goals has resulted 
in minimal morbidity, avoidance of secondary oper- 
ations, and excellent long-term results without tu- 
mor recurrence. 
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